Hormonal therapy recommended as a first-line treatment for menopausal vasomotor symptoms
Medical Xpress reports that the American College of Physicians has issued a new clinical guideline, published in Annals of Internal Medicine, recommending estrogen with progestogen (with a uterus) or estrogen alone (without a uterus) as first-line treatment for menopausal hot flashes and night sweats. SNRIs are suggested second-line; SSRIs, gabapentin or NKras third-line, with informed decision-making emphasized.
Why it matters: Relevant to perimenopausal and postmenopausal women in Maryland with hot flashes or night sweats, and to the primary care and women's health clinicians who treat them.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to medicalxpress.com. October 5, 2026.